19 May 2013
Keywords: mochida, seeks, otc, switch, epadel, japan, mid-size
Article | 09 February 2009
Japan's mid-size drugmaker Mochida Pharmaceutical plans to switch one of its mainstay products, Epadel (ethyl icosapentate or EPA) for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2009
17 May 2013
© 2013 thepharmaletter.com